We are live on ! Find out more
DAWN

Day One Biopharmaceuticals
DAWN

Delisted

DAWN was delisted on the 22nd of April, 2026.

Back to rankings

130 hedge funds and large institutions have $952M invested in Day One Biopharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 56 increasing their positions, 35 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more repeat investments, than reductions

Existing positions increased: 56 | Existing positions reduced: 35

5% more call options, than puts

Call options by funds: $813K | Put options by funds: $775K

1% more capital invested

Capital invested by funds: $941M → $952M (+$10.5M)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

7% less funds holding

Funds holding: 140 → 130 (-10)

17.95% less ownership

Funds ownership: 107.12% → 89.17% (-18%)

41% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 22

Holders
130
Holders Change
-10
Holders Change %
-7.14%
% of All Funds
2.06%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
13
Increased
56
Reduced
35
Closed
22
Calls
$813K
Puts
$775K
Net Calls
+$38K
Net Calls Change
-$391K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$14.7M
2
PHS
PFM Health Sciences
California
+$14.1M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$5.39M
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$4.8M
5
B
Braidwell
Connecticut
+$4.61M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$20M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$18.3M
3
Citadel Advisors
Citadel Advisors
Florida
-$9.98M
4
Goldman Sachs
Goldman Sachs
New York
-$9.74M
5
LGM
Logos Global Management
California
-$7.76M
Name Holding Trade Value Shares
Change 		Change in
Stake
Northwestern Mutual Wealth Management
126
Northwestern Mutual Wealth Management
Wisconsin
$184 +$196 +15 New
PNC Financial Services Group
127
PNC Financial Services Group
Pennsylvania
$49 +$52 +4 New
LGM
128
Logos Global Management
California
– -$7.76M -650,000 Closed
MIM
129
Monashee Investment Management
Massachusetts
– -$2.39M -199,900 Closed
Renaissance Technologies
130
Renaissance Technologies
New York
– -$1.66M -139,164 Closed
CH
131
CVI Holdings
Delaware
– -$955K -80,000 Closed
JF
132
Jump Financial
Illinois
– -$836K -70,031 Closed
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
133
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
– -$645K -54,000 Closed
DKCM
134
Davidson Kempner Capital Management
New York
– -$477K -40,000 Closed
Bank of Montreal
135
Bank of Montreal
Ontario, Canada
– -$507K -37,895 Closed
Jane Street
136
Jane Street
New York
– -$478K -36,611 Closed
Tudor Investment Corp
137
Tudor Investment Corp
Connecticut
– -$336K -28,163 Closed
DTL
138
Dynamic Technology Lab
Singapore
– -$279K -23,355 Closed
XT
139
XTX Topco
Cayman Islands
– -$204K -17,049 Closed
Two Sigma Advisers
140
Two Sigma Advisers
New York
– -$196K -16,400 Closed
BCM
141
Bayesian Capital Management
New York
– -$189K -15,834 Closed
GT
142
Glenmede Trust
Pennsylvania
– -$203K -15,209 Closed
AQR Capital Management
143
AQR Capital Management
Connecticut
– -$172K -14,404 Closed
NRD
144
Nebula Research & Development
New York
– -$148K -12,380 Closed
LCM
145
Laurion Capital Management
New York
– -$121K -10,134 Closed
Belvedere Trading
146
Belvedere Trading
Illinois
– -$71K -5,945 Closed
Russell Investments Group
147
Russell Investments Group
United Kingdom
– -$42.1K -3,530 Closed
LSA
148
Leonteq Securities AG
Switzerland
– -$8.36K -700 Closed
Simplex Trading
149
Simplex Trading
Illinois
– -$1.4K -107 Closed
C
150
Covestor
United Kingdom
– -$13 -1 -10%
3 4 5
6
7

DAWN Hedge Fund Activity: Q3 2023 in Review

130 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Day One Biopharmaceuticals (DAWN) for Q3 2023, worth a combined $952M — up 1.1% from $941M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of DAWN and 13 opened new positions — a net loss of 9 holders — while 35 trimmed existing stakes and 56 added.

The largest buyer was BlackRock, adding an estimated $14.7M. The largest seller was Fidelity Investments, cutting an estimated $20M.

  • 130 institutional investors held Day One Biopharmaceuticals (DAWN) as of Q3 2023, down from 140 in Q2 2023.
  • Funds reported $952M of Day One Biopharmaceuticals stock for Q3 2023, up 1.1% quarter-over-quarter.
  • 13 funds opened new Day One Biopharmaceuticals positions in Q3 2023 and 22 closed out, a net change of -9 holders.
  • The largest Day One Biopharmaceuticals buyer in Q3 2023 was BlackRock, an estimated $14.7M added.
  • The largest Day One Biopharmaceuticals seller in Q3 2023 was Fidelity Investments, an estimated $20M sold.

Based on aggregated 13F filings for Q3 2023.